The DIPK2B antibody is designed to target the Disco-interacting protein 2B (DIPK2B), a less-characterized protein implicated in cellular signaling and structural regulation. DIPK2B belongs to a conserved protein family with potential roles in cell adhesion, cytoskeletal organization, and intracellular trafficking, though its precise molecular functions remain under investigation. Studies suggest associations with neurological processes and developmental pathways, possibly interacting with DISC1 (Disrupted in Schizophrenia 1), a protein linked to neuropsychiatric disorders. The antibody, typically produced in hosts like rabbits or mice using immunogenic peptide fragments, enables detection of DIPK2B expression in various experimental models via techniques like Western blotting, immunohistochemistry, or immunofluorescence. Its development supports ongoing research into DIPK2B's involvement in diseases such as cancer, neurodegenerative conditions, or psychiatric disorders, where aberrant expression or mutations may contribute to pathogenesis. Validated for specificity and sensitivity, this tool aids in elucidating DIPKK2B's subcellular localization, interaction networks, and regulatory mechanisms, offering insights into its biological and clinical relevance.